The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Outcome criteria in smoking cessation trials: proposal for a common standard
Abstract
Smoking cessation treatment is now integrated into many health-care systems and a major research effort is under way to improve current success rates. Until now results from randomized clinical trials have been reported in many different ways, leading to problems of interpretation. We propose six standard criteria comprising the 'Russell Standard' (RS). These criteria are applicable to trials of cessation aids where participants have a defined target quit date and there is face-to-face contact with researchers or clinic staff, as follows. (1) Follow-up for 6 months (RS6) or 12 months (RS12) from the target quit date or the end of a predefined 'grace period'; (2) self-report of smoking abstinence over the whole follow-up period allowing up to five cigarettes in total; (3) biochemical verification of abstinence at least at the 6-month or 12-month follow-up point; (4) use of an 'intention-to-treat' approach in which data from all randomized smokers are included in the analysis unless they have died or moved to an untraceable address (participants who are included in the analysis are counted as smokers if their smoking status at the final follow-up cannot be determined); (5) following-up 'protocol violators' and using their true smoking status in the analysis; and (6) collecting follow-up data blind to smokers' allocation to trial group. We believe that these criteria provide the best compromise between practicability and surrogacy for long-term cessation and will enable meaningful comparison between studies. There may be good reasons why other outcome criteria would also be reported, and studies that involve interventions with special groups or where there is no designated target quit date or face to face contact would need to adapt these criteria accordingly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“authors like Benowitz et al. (2020) and West et al. (2005) suggest that abstinence outcomes are also reliable in those studies in which biochemical verification is not feasible, such as those in which the data are collected by phone or through the internet or when personal contact is limited.”
From Evaluation of effectiveness and acceptability of a psychological treatment for smoking cessation combined with a smartphone App: A pilot study (2024) · cites this paper as West et al., 2005
In the citing paper
“Study participants who (a) did not attend a follow-up visit, or (b) did not have a CO measurement, or (c) whose measured CO value exceeded the threshold of 9 ppm defined as critical (West et al., 2005) were classified as smokers.”
From Hypnotherapy compared to cognitive-behavioral therapy for smoking cessation in a randomized controlled trial (2024) · cites this paper as West et al., 2005
In the citing paper
“The primary outcome measure was 12 months continuous abstinence (CA) according to the Russell standard (West et al., 2005). This is defined as self-report of having smoked no more than five cigarettes since the end of treatment (and during all assessments 1, 6, 9, and 12 months later), supported by negative biochemical validation (CO < 10 ppm).”
From Hypnotherapy compared to cognitive-behavioral therapy for smoking cessation in a randomized controlled trial (2024) · cites this paper as West et al., 2005
In the citing paper
“In accordance with the Russell standard (West et al., 2005), a CO measurement of 10 or more parts per million was defined as indicative of current smoking.”
From Hypnotherapy compared to cognitive-behavioral therapy for smoking cessation in a randomized controlled trial (2024) · cites this paper as West et al., 2005
Citations
Cites
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710233371703 · Cited by 1,262
Measures of abstinence in clinical trials: issues and recommendations
Hughes, J. R., Keely, J. P., NIAURA, R. S., Ossip-Klein, D. J., RICHMOND, R. L., & Swan, G. E. (2003) · Nicotine & Tobacco Research · doi:10.1093/ntr/5.1.13 · Cited by 1,058
Interventions for promoting smoking cessation during pregnancy
Lumley, J., Chamberlain, C., Dowswell, T., Oliver, S., Oakley, L., & Watson, L. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub3 · Cited by 890
Treating Tobacco Use and Dependence
Goolsby, M. J. (2001) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2001.tb00227.x · Cited by 718
Measures of abstinence in clinical trials: issues and recommendations
Hughes, J. R., Keely, J. P., NIAURA, R. S., Ossip-Klein, D. J., RICHMOND, R. L., & Swan, G. E. (2003) · Nicotine & Tobacco Research · doi:10.1080/1462220031000070552 · Cited by 712
Interventions for promoting smoking cessation during pregnancy
Lumley, J., Oliver, S. R., Chamberlain, C., & Oakley, L. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub2 · Cited by 675
Lancaster, T. (2000) · BMJ · doi:10.1136/bmj.321.7257.355 · Cited by 565
Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking.
Russell, M. A., Merriman, R., Stapleton, J., & Taylor, W. (1983) · BMJ · doi:10.1136/bmj.287.6407.1782 · Cited by 248
Self-citationProchaska, J. O., Velicer, W. F., Fava, J. L., Ruggiero, L., Laforge, R. G., Rossi, J. S., Johnson, S. S., & Lee, P. A. (2001) · Preventive Medicine · doi:10.1006/pmed.2000.0767 · Cited by 157
Cited by
Sorted by citations
Items 901–1,000 of 1,001
Haarmann, H., Gossler, A., Herrmann, P., Bonev, S., Nguyen, X. P., Hasenfuss, G. P., Andreas, S., & Raupach, T. (2016) · Tobacco Induced Diseases · doi:10.1186/s12971-016-0091-x · Cited by 5
“Smoking status was biochemically validated, and we took a conservative approach by treating all subjects with missing data on their smoking status as smokers [38].”
MethodFucito, L. M., Wu, R., O’Malley, S. S., Hanrahan, T. H., Ikomi, J. T., Muvvala, S. B., Carroll, K. M., & Gueorguieva, R. V. (2020) · The Journal of Smoking Cessation · doi:10.1017/jsc.2020.13 · Cited by 5
Cunningham, J. A., & Kushnir, V. (2013) · Addiction · doi:10.1111/add.12111 · Cited by 5
Kendrick, T. (2006) · PubMed Central · Cited by 5
Subtypes of Smokers who Attend Psychological Treatment in Order to Stop Smoking
del Río, E. F., Becoña, E., & López‐Durán, A. (2011) · Substance Use & Misuse · doi:10.3109/10826084.2011.561467 · Cited by 5
Brunskill, D. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.196.5.353 · Cited by 5
The use of the RCQ-D in patients with poly drug abuse
Raes, V., Oene, G. H. D. W.-V., Velasquez, M. M., Maeseneer, J. D., & de Jong, C. A. J. (2009) · Addiction Research & Theory · doi:10.3109/16066350903291066 · Cited by 5
PURLs: "Cold turkey" works best for smoking cessation.
Smith, D. K., Miller, D. E., & Mounsey, A. (2017) · Europe PMC (PubMed Central) · Cited by 5
System change interventions for smoking cessation
Thomas, D., Abramson, M. J., Bonevski, B., & George, J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010742 · Cited by 5
Mohanty, U., Kumar, K., Sharma, G., Sarit, S., & Rath, H. (2025) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaf091 · Cited by 4
“The literature showed a decreasing trend from baseline to 3 months 12,20 and baseline to 6 months.”
Murray, R. L., Baldwin, D., Brain, K. E., Britton, J. R., Chalitsios, C. V., Crosbie, P. A. J., Lewis, S., McCutchan, G. M., Parrott, S., Quaife, S. L., et al. (2026) · Thorax · doi:10.1136/thorax-2025-224217 · Cited by 4
“24 A likelihood ratio test was used to test for interaction by sex, Index of Multiple Deprivation (IMD), level of education, age and scan outcome with the effect of the intervention on abstinence.”
Taylor, A. H., Thompson, T., Streeter, A., Chynoweth, J., Snowsill, T., Ingram, W. M., USSHER, M. H., Aveyard, P. N., Murray, R. L., Harris, T. J., et al. (2023) · Addiction · doi:10.1111/add.16129 · Cited by 4
Kroczek, A., Schröder, B., Rosenbaum, D., Mühleck, A., Diemer, J., Mühlberger, A., Ehlis, A., & Batra, A. (2025) · Addiction Science & Clinical Practice · doi:10.1186/s13722-025-00561-2 · Cited by 4
“The primary outcome measure was continuous abstinence according to the Russell Standard [24], with fewer than five smoked cigarettes altogether according to self-reports and biochemical validation by a CO measurement (cutoff 10 ppm, piCO Smokerlyzer, Bedfont, England).”
Pothirat, C., Phetsuk, N., Liwsrisakun, C., & Deesomchok, A. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s80506 · Cited by 4
Validity of urges to smoke measures in predicting smoking relapse during treatment in primary care
Kotz, D., van Rossem, C., Viechtbauer, W., Spigt, M., & van Schayck, O. C. P. (2021) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-021-00259-3 · Cited by 4
Wittekind, C. E., Takano, K., Sckopke, P., Winkler, M. H., Werner, G. G., Ehring, T. W., & Rüther, T. (2022) · Trials · doi:10.1186/s13063-022-06155-6 · Cited by 4
“Long-Wittekind term abstinence is assessed following recommendations by West et al. [62], defined by the Russell Standard (RS) which incorporates six criteria: (1) continuous abstinence of 6 months starting with the quit date, (2) RS abstinence, that is, not having smoked more than five cigarettes…”
Notley, C. J., Brown, T. J., Bauld, L., Clark, A., Duneclift, S., Gilroy, V., Harris, T. J., Hardeman, W., Holland, R., Howard, G., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-076458 · Cited by 4
Lin, H., Li, M., Li, X., Chang, C. H., & Liu, G. G. (2023) · Journal of Global Health · doi:10.7189/jogh.13.04133 · Cited by 4
“Those who declined to be involved in subsequent data collection were counted as smokers [20].”
BackgroundMoss-Alonso, E., Martínez-Vispo, C., López‐Durán, A., & Becoña, E. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01317-w · Cited by 4
“Additionally, smoking cessation literature suggests that when in-person contact is not feasible, self-reported abstinence seems to be a reliable measure (Benowitz et al., 2020; West et al., 2005).”
Zhao, S. Z., Xue, W., Wu, Y. S., Derek, C., Luk, T. T., Tong, H. S. C., Lai, V., Hing, L. T., & Ping, W. M. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01328-7 · Cited by 4
“Participants who were lost to follow-up were treated as non-responders (by intention-to-treat) for the subsequent interventions (West et al., 2005).”
Behavioral Activation mHealth Application for Smoking Cessation: A Randomized Controlled Pilot Trial
Heffner, J. L., Serfozo, E., Baker, K., Gasser, M. L., Watson, N. L., Daughters, S. B., Becoña, E., & McClure, J. B. (2024) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntae137 · Cited by 6
Huddlestone, L., Shoesmith, E., Pervin, J., Stevens, R., Gilbody, S. M., & Ratschen, E. (2024) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntae237 · Cited by 4
“33 Publication bias was assessed using funnel plots.”
Evaluation of smoking cessation drug use and outcomes in the Netherlands
Beest, F. J. A. P., Overbeek, J. A., Smulders, M., van Spiegel, P. I., Meerding, W. J., & Herings, R. M. C. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2010.551165 · Cited by 4
“Gender Male 286 (47) 76 (44) 107 (50) 11 (35) 82 (47) Female 326 (53) 97 (56) 109 (50) 20 (65) 94 (53) Age (years, mean SD) 48 11 47 11 48 12 52 11 49 11 Reported comorbidities Cardiovascular diseases 83 (14) 20 (12) 29 (13) 5 (16) 28 (16) Asthma 53 (9) 22 (13) 8 (4) 6 (19) 17 (10) COPD 110 (18) 33 (19) 26 (12) 4 (13)…”
Härter, M. C., Bartsch, A.-L., Egger, N., König, H., Kriston, L., Schulz, H., Tiemann, M., Brütt, A. L., & Buchholz, A. (2015) · Trials · doi:10.1186/s13063-015-0977-6 · Cited by 4
“In the analysis of abstinence rates, patients lost to follow-up will be assumed to have returned to smoking [27, 28].”
BackgroundMarkham, W. A., Bridle, C., Grimshaw, G. M., Stanton, A., & Aveyard, P. N. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-336 · Cited by 4
“The primary outcome was quitting success at 4 weeks post quit day, as judged according to the Russell standard [14,15], meaning intention to treat and biochemically verified.”
MethodBrown, J. (2016) · Addiction · doi:10.1111/add.13449 · Cited by 4
“The positive impact of a ‘Russell Standard’ for evaluating clinical interventions is testament to the importance of common language in the field [7].”
BackgroundGrischott, T., Senn, O., Rosemann, T. J., Frei, A. L., Cornuz, J., Martin‐Diener, E., & Neuner‐Jehle, S. (2019) · Trials · doi:10.1186/s13063-018-3071-z · Cited by 4
Gjorgjievski, D., Ristovska, R., Stavrikj, K., Farley, A., Adab, P., Adams, R. L., Dickens, A., Enocson, A., Stanoevski, G., Gale, N. K., et al. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.4519 · Cited by 4
Klonizakis, M., Gumber, A., McIntosh, E., & Brose, L. S. (2021) · Biology · doi:10.3390/biology10111208 · Cited by 6
“Outcomes Outcome measures (Box 2) were recorded three days after the quit date, when all included participants reported abstinence from smoking, biochemically-validated by exhaled air measurement of <10 ppm carbon monoxide [22], with them confirming that they were following the allocated treatment.”
Method‘Analysing a parent’s capacity to change: towards a model for child protection social workers’
Houston, S., & Swords, C. (2020) · Journal of Social Work Practice · doi:10.1080/02650533.2020.1769581 · Cited by 4
McMeekin, N., Sinclair, L., Bauld, L., Tappin, D. M., Mitchell, A. S., & Boyd, K. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038827 · Cited by 4
Interventions for smokeless tobacco use cessation
Livingstone‐Banks, J., Siddiqui, F., Croucher, R., Mehrotra, R., Vidyasagaran, A. L., & Siddiqi, K. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015314 · Cited by 4
Dai, S., Chan, M. H. M., Kam, R. K. T., Li, A. M., Au, C. T., & Chan, K. C. C. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.798351 · Cited by 4
“Individuals were considered as successful reducers if their urine cotinine level was ≤50% of their baseline level (34, 41), and successful quitters if their urine cotinine concentration was ≤115ug/L (34, 42).”
BackgroundTaylor, A. H., Thompson, T., Streeter, A., Chynoweth, J., Snowsill, T., Ingram, W. M., USSHER, M. H., Aveyard, P. N., Murray, R. L., Harris, T. J., et al. (2023) · Health Technology Assessment · doi:10.3310/kltg1447 · Cited by 4
Saito, J., Odawara, M., Fujimori, M., Kuchiba, A., Oyamada, S., Swe, K. T., Saito, E., Fukai, K., Tatemichi, M., Nakamura, M., et al. (2023) · Implementation Science Communications · doi:10.1186/s43058-023-00444-0 · Cited by 4
“Health outcomes The primary health outcome will be the salivary cotinine-validated 7-day point-prevalence abstinence rate 6 months after the initial session, according to the Russell Standard [29].”
MethodGjorgjievski, D., Stavrikj, K., Jordan, R. E., Adab, P., Stanoevski, G., Stamenova, A., Krstevska, E., Simonovska, S., Trpcheski, F., Adams, R. L., et al. (2023) · BMC Public Health · doi:10.1186/s12889-023-16644-1 · Cited by 4
“In accordance with the Russell Standard [25], an intention to treat analysis was conducted for smoking cessation outcomes, treating those lost to follow-up as smokers, and untrace-able participants were removed from the analysis.”
MethodInfluencia de la sensibilidad a la ansiedad en una intervención psicológica para dejar de fumar
Martínez-Vispo, C., del Río, E. F., López‐Durán, A., & Becoña, E. (2016) · Revista de Psicopatología y Psicología Clínica · doi:10.5944/rppc.vol.21.num.1.2016.15977 · Cited by 5
Nollen, N. L., Cox, L. S., Mayo, M. S., Ellerbeck, E. F., Madhusudhana, S., & Ahluwalia, J. S. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.05.011 · Cited by 4
“—All primary analyses on smoking cessation will be conducted using intent-to-treat and will code those lost to follow-up as smokers per the Russell Standard [63].”
MethodLycett, D., Aveyard, P. N., Farmer, A. A., Lewis, A. L., & Munafo, M. R. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-032271 · Cited by 4
Drogenmissbrauch und -abhängigkeit
Küfner, H., & Metzner, C. (2011) · Springer-Lehrbuch · doi:10.1007/978-3-642-13018-2_34 · Cited by 4
Nutritious food intake: a new competitive advantage for organizations?
Houghton, J. D., Neck, C. P., & Cooper, K. H. (2009) · International Journal of Workplace Health Management · doi:10.1108/17538350910970228 · Cited by 5
Slimming World in Stop Smoking Services (SWISSS): study protocol for a randomized controlled trial
Lycett, D., Aveyard, P. N., Farmer, A. A., Lewis, A. L., & Munafo, M. R. (2013) · Trials · doi:10.1186/1745-6215-14-182 · Cited by 4
“Abstinence is prolonged abstinence, defined according to the Russell Standard as self-report of no more than five cigarettes since 2 weeks following quit day and expired CO less than 10 ppm [21].”
BackgroundMethodTypes of Smokers Who Seek Smoking Cessation Treatment According to Psychopathology
Martínez, Ú., del Río, E. F., López‐Durán, A., Martínez-Vispo, C., & Becoña, E. (2017) · Journal of Dual Diagnosis · doi:10.1080/15504263.2017.1398360 · Cited by 4
Behavioral activation and smoking cessation outcomes: The role of depressive symptoms
Martínez-Vispo, C., López‐Durán, A., Senra, C., Rodríguez‐Cano, R., del Río, E. F., & Becoña, E. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.106183 · Cited by 5
Hubacek, J. A., Kurcová, I., Marešová, V., Pánková, A., Štěpánková, L., Zvolská, K., Lánská, V., & Králíková, E. (2019) · Biomedical Papers · doi:10.5507/bp.2019.058 · Cited by 4
Lindson, N., Michie, S., & Aveyard, P. N. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaa123 · Cited by 4
O’Donnell, M., Baird, J., Cooper, C. C., Crozier, S., Godfrey, K. M., Geary, M. P., Inskip, H. M., & Hayes, C. B. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17217991 · Cited by 4
Bonevski, B., Rich, J., Skelton, E., Garfield, J. B. B., Baker, A., Segan, C., GARTNER, C. E., Walker, N., Borland, R., Daglish, M. R. C., et al. (2022) · medRxiv · doi:10.1101/2022.05.15.22275118 · Cited by 4
“As recommended by the Russell Standard, [39] the primary analysis will be intention-to-treat (ITT); all consenting participants in the cohort will be included in the analysis.”
BackgroundMethodInfluentialTaylor, G. M. J., Sawyer, K., Jacobsen, P., Freeman, T. P., Blackwell, A., Daryan, S., Metcalfe, C., Kessler, D., Munafò, M. R., & Aveyard, P. (2025) · Addiction · doi:10.1111/add.16718 · Cited by 2
“[29].”
Bryant, J., Roberts-Barker, K., Mills, Z., Booth, K., Foster, J., Mersha, A. G., Maddox, R., Chamberlain, C., Bonevski, B., Segan, C., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-088501 · Cited by 3
Palo, M. P. D., Spirito, F. D., Garofano, M., Sorbo, R. D., Caggiano, M., Giordano, F., Bartolomeo, M. D., Pessolano, C., Giordano, M., Amato, M., et al. (2025) · Healthcare · doi:10.3390/healthcare13172125 · Cited by 3
“The following PICO model [18] was established to develop the research questions, search strategy, and the inclusion and exclusion criteria: [20,21].”
Pope, I., Halicka, Z., Clark, L., Stirling, S., Clark, A., & Notley, C. J. (2025) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaf200 · Cited by 3
Planning a Change Easily (PACE): A randomized controlled trial for smokers who are not ready to quit
García, F. I. S., Derefinko, K. J., Bursac, Z., Hand, S. B., & Klesges, R. C. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.03.007 · Cited by 3
Reinhardt, C., Harden, M., Herrmann‐Lingen, C., Rittmeyer, A., & Andreas, S. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02048-1 · Cited by 4
“Abbreviations CO: Carbon monoxide; BfArM: Bundesinstitut für Arzneimittel und Medizin‑ produkte; EORTC QLQ: European Organization Research Treatment Cancer— Quality of Life Questionnaire; EQ VAS: European Quality of Life—visual analog scale; GCP: Good clinical practice; HADS: Hospital Anxiety and Depression Scale; MPS…”
MethodInfluentialTane, M. P., Stevenson, L., Cameron, L., & Gould, G. S. (2022) · Australian Journal of Primary Health · doi:10.1071/py22023 · Cited by 3
Emery, J. L., Leonardi‐Bee, J., Coleman, T. J., McDaid, L., & Naughton, F. (2024) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntae026 · Cited by 3
“Outcome data were coded as “smoking” for all participants who were missing smoking outcomes (Russell Standard, considered a gold standard for the measurement of smoking cessation outcomes), 29 other than making a quit attempt, where a complete case analysis was used.”
MethodGuo, Z., Wu, Y. S., & Wang, M. P. (2024) · JMIR XR and spatial computing. · doi:10.2196/52893 · Cited by 3
“The intention to treat approach was adopted, assuming participants lost to follow-up did not change their smoking behaviors (eg, they made no quit attempts nor changed their daily cigarette consumption) [31].”
MethodTulloch, H. E., Greenman, P. S., Reed, J. L., Susinski, S., Kasos, E., Tasca, G. A., Mielniczuk, L. M., Wells, G. A., Sun, L. Y., & Johnson, S. M. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1564666 · Cited by 3
“Smoking status is reported by participants and confirmed with CO concentration ( 10 ppm) in an expired breath sample, using the Russell standard (West et al., 2005).”
How stable are stop smoking practitioner success rates over time?
Brose, L. S., West, R., & McEwen, A. (2014) · Translational Behavioral Medicine · doi:10.1007/s13142-014-0261-4 · Cited by 3
Self-citationClient Satisfaction With English Stop Smoking Services
May, S., & McEwen, A. (2011) · The Journal of Smoking Cessation · doi:10.1375/jsc.6.1.51 · Cited by 3
Updated information on smoking cessation management
Choi, M.-K., & Paek, Y. (2016) · Journal of Korean Medical Association · doi:10.5124/jkma.2016.59.11.872 · Cited by 3
Combining Education With Auricular Acupressure to Facilitate Smoking Cessation in Young Adults
Wang, Y.-Z., Wang, Y.-J., & Yeh, M. (2019) · Holistic Nursing Practice · doi:10.1097/hnp.0000000000000335 · Cited by 3
Thorley, R., Britton, J. R., Nyakutsikwa, B., Breton, M. O., Lewis, S., & Murray, R. L. (2019) · Addiction · doi:10.1111/add.14720 · Cited by 3
“If patients reported abstinence from smoking in line with the Russell Standard (25) a researcher visited the patient at home, work or in a convenient community setting to validate smoking status by measuring exhaled CO.”
BackgroundMethodKlemperer, E. M., & Lindson, N. (2019) · Tobacco Induced Diseases · doi:10.18332/tid/113378 · Cited by 3
Simmet, A., Teut, M., Schleicher, R., Bschaden, A., & Stroebele‐Benschop, N. (2020) · BMC Public Health · doi:10.1186/s12889-020-09232-0 · Cited by 3
“Smoking abstinence is defined as the self-reported continuous smoking cessation (≤ 5 cigarettes since the start date of their last attempt to quit) validated by the exhaled carbon monoxide test (< 10 ppm of carbon monoxide) [46].”
MethodGrischott, T., Senn, O., Frei, A. L., Rosemann, T. J., & Neuner‐Jehle, S. (2022) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntac159 · Cited by 3
Relationship of Weight Concerns to Body Mass Index in a Tobacco Treatment Program
Pánková, A., Králíková, E., Zvolská, K., Štěpánková, L., Roche, A. I., Clark, M. M., Schroder, D. R., & Croghan, I. T. (2023) · American Journal of Health Behavior · doi:10.5993/ajhb.47.2.21 · Cited by 3
Walker, N. K., Calder, A. J., Barnes, J., Laking, G. R., Parag, V., & Bullen, C. (2023) · BMC Public Health · doi:10.1186/s12889-023-16665-w · Cited by 4
“The primary outcome measure is six-month CA (Rus-sell Standard) defined as self-report of smoking not more than five cigarettes from the Quit date, supported by biochemical validation [30, 31].”
MethodKrolo-Wicovsky, F., Baumann, S., Tiede, A., Bischof, G., John, U., Gaertner, B., & Freyer‐Adam, J. (2023) · Addiction Science & Clinical Practice · doi:10.1186/s13722-023-00425-7 · Cited by 3
Leppin, C., Okpako, T., Brown, J., Garnett, C. V., & Perski, O. (2024) · Health Psychology Review · doi:10.1080/17437199.2024.2366189 · Cited by 5
“The most rigorous measure of abstinence (Piper et al., 2020; West et al., 2005) reported or made available by the study authors was extracted.”
InfluentialFinancial incentives to stop smoking: Potential financial consequences of different reward schedules
Valentelyte, G., Sheridan, A., Kavanagh, P. M., Doyle, F., & Sørensen, J. R. (2024) · Tobacco Prevention & Cessation · doi:10.18332/tpc/190617 · Cited by 3
“The QuitManager data capture the smoking quit rates and outcomes of all smoking individuals in Ireland who have used the Health Services Executive (HSE) stop smoking support program, in line with the Russell Standards for smoking cessation 10,11 .”
MethodLydom, L. N., Lauridsen, S. V., Liljendahl, M. S., Schmedes, A., Joensen, U. N., & Tønnesen, H. (2025) · Cancers · doi:10.3390/cancers17040713 · Cited by 3
“We planned to strengthen this study by validating successful cessation by CO measurement and urine cotinine [29].”
Acceptability and outcome of an Internet-based smoking cessation programme.
Fraser, T., McRobbie, H. J., Bullen, C., Whittaker, R., & Barlow, D. (2010) · PubMed · Cited by 3
Proctor, J., Naughton, F., Sloan, M. A., Hopewell, S., Brimicombe, J. D., Prevost, A. T., Wilson, E., Coleman, T. J., & Sutton, S. R. (2020) · JMIR Research Protocols · doi:10.2196/17160 · Cited by 3
“A saliva sample for biochemical validation: Participants who respond to the first question with A1 or A2 also receive a saliva sampling kit for biochemical validation (cotinine and anabasine in saliva are important biomarkers for determining a participant’s smoking status) [39,40].”
One Way to Leave Your Lover: The Role of Treatment in Changing Addictive Behaviors
Sobell, M. B. (2007) · Springer eBooks · doi:10.1007/978-0-387-71287-1_7 · Cited by 3
Comparing models of smoking treatment in Glasgow: interim report
Bauld, L., Briggs, A. H., Boyd, K., Chesterman, J., Ferguson, J., Judge, K., & Wilson, M. P. (2008) · Cited by 3
Störungen durch Konsum von Alkohol und illegalen Drogen
Bühringer, G., & Metz, K. (2008) · Springer eBooks · doi:10.1007/978-3-540-79543-8_17 · Cited by 4
Smoking cessation in patients requiring bronchoscopy: The Bronchoscopy AntiSmoking Study (BASIS)
Martucci, P., Sestini, P., Canessa, P. A., Brancaccio, L., Guarino, C., Barbato, N., Lodi, M., Coloretti, I., Donno, M. D., Sini, A., et al. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.08.002 · Cited by 3
McDonald, K. A., Papadopoulos, A., & Sunderland, E. (2012) · International Journal of Sexual Health · doi:10.1080/19317611.2011.640525 · Cited by 3
Kortrijk, H. E., Mulder, C. L., van Vliet, D., van Leeuwen, C., Jochems, E. C., & Staring, A. B. P. (2013) · Community Mental Health Journal · doi:10.1007/s10597-012-9582-2 · Cited by 5
Successful Smoking Cessation: the Role of Self-efficacy, Mindfulness and Demographic Factors
Boogar, I. R., & Mirkouhi, M. G. (2013) · Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences · Cited by 3
Cutting edge smoking cessation support: SCIMITAR+
Robson, D., & McNeill, A. D. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30131-2 · Cited by 3
Development of a biochemical marker to detect current breast milk intake
Addison, R., Hill, L., Bode, L., Robertson, B., Choudhury, B., Young, D., Wright, C. M., Relton, C., García, A. L., & Tappin, D. M. (2019) · Maternal and Child Nutrition · doi:10.1111/mcn.12859 · Cited by 3
Štěpánková, L., Králíková, E., Zvolská, K., Pánková, A., Adamcekova, Z., Kuhn, M., & Noland, D. H. (2020) · Addiction · doi:10.1111/add.15175 · Cited by 3
Ainscough, T., Mitchell, A. S., Hewitt, C. E., Horspool, M. J., Stewart, P., Ker, S., Colley, L., Paul, C., Hough, P., Hough, S., et al. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaa258 · Cited by 3
Contested knowledge: Introducing Fillmore, Kerr, Stockwell, Chikritzhs, and Bostrom ()
Heim, D. (2006) · Addiction Research & Theory · doi:10.1080/16066350500537622 · Cited by 3
Davidson, R. (2013) · Drugs Education Prevention and Policy · doi:10.3109/09687637.2013.835512 · Cited by 3
Yao, Y., Luk, T. T., Lau, O. S., Wu, Y. S., Weng, X., Ng, C. H., Cheung, Y. T. D., Lam, T. H., & Wang, M. P. (2025) · Addiction · doi:10.1111/add.70013 · Cited by 3
Holliday, R., Wilson, N., Ryan, V., Butcher, C., Homer, T. M., Watts, P., Kareithi, D. N., Blaylock, P., Ternent, L., Finch, R., et al. (2025) · Trials · doi:10.1186/s13063-025-08954-z · Cited by 15
“Note that this is not inflated for attrition in line with standard research practice in this field [41].”
Tang, J., Liu, X., Chen, S., Sun, Y., Zhu, M., Zhou, Z., Liu, Y., Yang, J., Chen, W., & Liao, Y. (2025) · Addiction · doi:10.1111/add.70239 · Cited by 2
“The primary outcome measure was self-reported continuous smoking abstinence rate (smoke no more than 5 cigarettes from the day of quitting smoking to 26 weeks) [20], biochemically validated at 26 weeks after quit day.”
Mobile Chat Messaging for Smoking Relapse Prevention
Luk, T. T., Su, X., Wong, V., Chan, H. C.-H., Wong, G. N.-T., Lee, J. K. H., Ho, S. Y., Lam, T. H., Cheung, Y. T. D., & Wang, M. P. (2026) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.7439 · Cited by 2
Wittekind, C. E., Takano, K., Motka, F., Winkler, M. H., Werner, G. G., Ehring, T. W., & Rüther, T. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20250189 · Cited by 2
Training health professionals in smoking cessation
Sharrad, K. J., Carson‐Chahhoud, K., Verbiest, M. E. A., Greenslade, S., Parkhouse, T., Assendelft, W. J., Crone, M. R., & Livingstone‐Banks, J. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000214.pub3 · Cited by 3
Supporting smoking cessation in pregnancy
Edwins, J. (2013) · British Journal of Midwifery · doi:10.12968/bjom.2013.21.3.174 · Cited by 2
Leone, S., & Carrozzino, R. (2015) · Clinical Pharmacology & Biopharmaceutics · doi:10.4172/2167-065x.1000152 · Cited by 2
Papadakis, S., Vyzikidou, V. K., Vivilaki, V. G., Vardavas, C. I., Loukopoulou, A. N., Peleki, T., Evangelopoulou, V., & BEHRAKIS, P. K. (2018) · European Journal of Midwifery · doi:10.18332/ejm/99543 · Cited by 2
The estimand framework and its application in substance use disorder clinical trials: a case study
Roydhouse, J. K., Floden, L. L., Tomko, R. L., Gray, K. M., & Bell, M. L. (2021) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2021.1976199 · Cited by 2
“Additionally, although this approach can produce biased results (34,35), it is one of the criteria in the Russell Standard (36), which is frequently used in smoking cessation trials.”
Theodoulou, A., Lindson, N., Fanshawe, T. R., Thomas, J., Nollen, N. L., Ahluwalia, J. S., Leavens, E. L. S., & Hartmann‐Boyce, J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015120 · Cited by 2
Heavey, L., Wright, R., Ryan, M., Murphy, E., Blake, M., Cloney, B., Kavanagh, P. M., & Doyle, F. (2022) · Tobacco Prevention & Cessation · doi:10.18332/tpc/149910 · Cited by 2
Metadata
- Authors
- West, R., Hajek, P., Stead, L., & Stapleton, J.
- Affiliations
- University College London (GB)
- University of Oxford (GB)
- King's College London (GB)
- Corresponding author
- West, Robert
- ORCID
- West, Robert
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2005-03
- Volume
- 100
- Issue
- 3
- Pages
- 299-303
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2138106394
- Cited by
- 1,285
- References
- 15
- Citations by year
- 2026: 38 · 2025: 68 · 2024: 84 · 2023: 77 · 2022: 79 · 2021: 69 · 2020: 75 · 2019: 85 · 2018: 58 · 2017: 84 · 2016: 64 · 2015: 77 · 2014: 67 · 2013: 70 · 2012: 56
- FWCI
- 17.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Addiction (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- smoking cessation, outcome criteria, cessation aids, smoking abstinence, intention-to-treat analysis, grace period, trial comparability
- MeSH terms
- Humans, Research Design, Randomized Controlled Trials as Topic, Smoking Cessation, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review